Drug General Information
Drug ID	D04KDB
Former ID	DNC004499
Drug Name	6-Imidazol-1-yl-3,4-dihydro-1H-quinolin-2-one
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[526726]
Structure		Download 2D MOL 3D MOL
Formula	C12H11N3O
Canonical SMILES	C1CC(=O)NC2=C1C=C(C=C2)N3C=CN=C3
InChI	1S/C12H11N3O/c16-12-4-1-9-7-10(2-3-11(9)14-12)15-6-5-13-8-15/h2-3,5-8H,1,4H2,(H,14,16)
InChIKey	BDMKPUAZENLRDY-UHFFFAOYSA-N
PubChem Compound ID	13885278
Target and Pathway
Target(s)	CGMP-inhibited 3',5'-cyclic phosphodiesterase A	Target Info	Inhibitor	[526726]
KEGG Pathway	Purine metabolism
	cGMP-PKG signaling pathway
	cAMP signaling pathway
	Morphine addiction
Reactome	cGMP effects
	G alpha (s) signalling events
WikiPathways	miR-targeted genes in muscle cell - TarBase
	miR-targeted genes in lymphocytes - TarBase
References
Ref 526726	J Med Chem. 1992 Feb 21;35(4):620-8.3,4-Dihydroquinolin-2(1H)-ones as combined inhibitors of thromboxane A2 synthase and cAMP phosphodiesterase.
Ref 526726	J Med Chem. 1992 Feb 21;35(4):620-8.3,4-Dihydroquinolin-2(1H)-ones as combined inhibitors of thromboxane A2 synthase and cAMP phosphodiesterase.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.